Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Medical Tourism Experts

Analysis of: Anti-inflammatory Drugs Do Not Improve Cognitive Function in Older Adults (pharmalive.com)
More contradictory data.  But without a clear case, it does not make sense to prescribe NSAIDS to patients with AD.
Analysis of: Medicare PHR Pilot is Underway in South Carolina (www.govhealthit.com)
Medicare has launched a pilot online personal health records program in South Carolina.  This programs provides thousands of Medicare beneficiaries access to personal health records (PHRs) containing their hospital and physician claims information.  Although information on their prescription...
Analysis of: Lawmakers Fault FDA on Heparin (online.wsj.com)
Issue: Risk of fraud motivated contamination, and vendor quality failures, could and should have been seen long in advance, and nearly every drug and device faces this threat.  Outsourcing Managers have been entirely cost driven, without exercising adequate management of supply chain...
Analysis of: Genentech and Biogen Idec Announce Top-Line Results From Phase II/III Clinical Study of Rituxan in Systemic Lupus Erythematosus (www.pipelinereview.com)
The problem with lupus studies lies in study design.  While true for all trials, this is specially true for lupus since the disease is not "uniform".  Patients have so many different varieties of lupus that the inclusion/exclusion criteria can make or break a study before it starts.
Analysis of: Federal Healthcare Agencies Gear Up for NHIN Trials (www.healthcareitnews.com)
For decades, the Holy Grail for those pushing electronic health information technologies has been the ability to produce for physicians and other caregivers at the point of care complete information about patients from all sources to facilitate intelligent decision making. ...
Analysis of: FDA Embarks on Major Hiring Initiative for its Public Health Mission (pharmalive.com)
In this publications there is am implication that the FDA will approve things faster as the FDA will after hiring so many people with fancy science backgrounds.  This might be true but it probably won't be the case.
Analysis of: Cytheris Announces New Phase I Study of Interleukin-7 As Immunotherapy In Treatment of Bone Marrow or Peripheral Blood Stem Cell Transplant Patients (www.pipelinereview.com)
IL-7 is important for B and T cell development.  But both cells require multiple cytokines, in the correct chronological order and appropriate amounts, for optimum results.
Joe Atkins, RN, MBA, CNN, CHT, Chief Executive Officer
Medical Concepts & Innovations
Analysis of: UPDATE: FDA Head Sees Economic Fraud Behind Tainted Heparin (www.reuters.com)
First, and foremost, the only working link for this article can be found at: http://www.reuters.com/article/domesticNews/idUSWAT00934620080415?feedType=RSS&feedName=domesticNews Although there is no proof offered in the article to substantiate the suggestion of fraud, there is enough circumstantial...
Robert Forster, MD, Healthcare Consultant
Robert Forster, MD, Healthcare Consultant
Robert Forster, MD
Analysis of: Experts see boost to genetic testing from US bill (www.reuters.com)
There are many reasons why the commercialization of human genome "information" will be ABSOLUTE CHAOS AND COST.  The three most prominent are the following:   1. Physician education is almost devoid of practical genomic teachings except for Diabetes and lipid disorders.   2. ...
Joe Atkins, RN, MBA, CNN, CHT, Chief Executive Officer
Medical Concepts & Innovations
Analysis of: FDA fees eyed to boost food, drug safety (www.usatoday.com)
One only has to read about the Heparin debacle, which has killed, at least, 81 Americans, to realize that there is a serious issue with the quality of medicines produced in China.  Manufacturing of medical food and consumer goods in China is growing at such a rate, the Chinese government has neither...

Previous Page : 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Next61 to 70 of 667

Analytics


Generated at 2009-01-07T19:00:58.307